Loading organizations...
ENEA Tech e Biomedical operates as a private foundation fostering innovation within the biomedical sector. It primarily functions to bridge the gap between fundamental and pre-clinical scientific research and industrial application, identifying and supporting projects with high potential. The organization strategically invests in emerging technologies and methodologies, such as new diagnostic approaches in oncology, to accelerate their development and market readiness. This involves facilitating the transition of scientific discoveries into practical solutions.
The entity was established as a private foundation, operating under the vigilant oversight of both the Ministry of Business and Made in Italy and the Ministry of Health. This institutional framework underscores its public utility mission to bolster national capabilities in biomedical innovation. While not founded by a single individual entrepreneur, its operational direction is guided by leadership such as Giovanni Tria, who serves as president, ensuring its mandate to support strategic advancements.
Its core beneficiaries include scientific researchers, nascent biomedical ventures, and established industrial partners seeking to develop impactful health solutions. ENEA Tech e Biomedical’s overarching vision is to cultivate a robust ecosystem for biomedical research and development in Italy, ultimately translating scientific progress into tangible improvements in healthcare and patient outcomes, driving forward the sector's capabilities.
ENEA Tech e Biomedical has 2 tracked investments across 2 companies. The latest tracked deal is $1.4M Seed in Recornea in August 2025.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Aug 7, 2025 | Recornea | $1.4M Seed | Enea Tech E Biomedical | B Heroes, Caique Holding, DN Lemans, Entrepreneur First, G Factor, Health Wildcatters, Scientifica Venture Capital |
| Feb 13, 2025 | Newronika | $15.9M Series B | Enea Tech E Biomedical | — |